Get the Stockscreener App
3.60
1.41%
0.05
After Hours:
3.60
Cytek Biosciences Inc stock is traded at $3.60, with a volume of 1.53M.
It is up +1.41% in the last 24 hours and up +5.88% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$3.55
Open:
$3.49
24h Volume:
1.53M
Relative Volume:
1.30
Market Cap:
$455.97M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-40.00
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
+8.11%
1M Performance:
+5.88%
6M Performance:
-30.10%
1Y Performance:
-46.35%
1-Day Range:
$3.46
$3.605
1-Week Range:
$3.38
$3.78
52-Week Range:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.60 | 449.64M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
Cytek Biosciences Inc Stock (CTKB) Latest News
How strong is Cytek Biosciences Inc. company’s balance sheetSwing Trade Forecasts For Smart Trading - jammulinksnews.com
How does Cytek Biosciences Inc. compare to its industry peersStock Market Updates For Beginners - jammulinksnews.com
Can Cytek Biosciences Inc. hit a new high this monthShort Term Opportunity Finder with Tools - Newser
Cytek Biosciences Inc.’s volatility index tracking explainedHigh Reward Picks with Tight Risk Control - Newser
Is Cytek Biosciences Inc. Stock Overbought or Oversold RSI Indicator AnalysisTrade Safety Matrix for Conservative Traders - Newser
Cytek Biosciences And 2 Other Penny Stocks Worth Watching - simplywall.st
How Interest Rate Changes Impact Cytek Biosciences Inc. Stock PerformanceEntry and Exit Strategy Optimizer Tool Tested - metal.it
Can machine learning forecast Cytek Biosciences Inc. recoveryFree High Accuracy Alerts for ROI Traders - Newser
Using Bollinger Bands to evaluate Cytek Biosciences Inc.AI Pattern Recognition and Trade Prediction - Newser
What machine learning models say about Cytek Biosciences Inc.Risk Managed Intraday Trade Alerts Increase in Volume - metal.it
What makes Cytek Biosciences Inc. stock price move sharplySafe Entry Screening with Data Backed Analysis - Newser
Multi asset correlation models including Cytek Biosciences Inc.Stock Portfolio Risk and Return Analysis - Newser
Real Time Data Flags Unusual Activity in Cytek Biosciences Inc.Smart Money Tracking Signal Generator Activated - metal.it
Great Week for Cytek Biosciences, Inc. (NASDAQ:CTKB) Institutional Investors After Losing 42% Over the Previous Year - 富途牛牛
How volatile is Cytek Biosciences Inc. stock compared to the marketAchieve rapid portfolio growth with expert help - jammulinksnews.com
Cytek Biosciences Inc. Price Holds Above Key Fib LevelEntry Alert Based on Volume Spikes Detected - metal.it
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt Sensibly? - simplywall.st
How to use a screener to detect Cytek Biosciences Inc. breakoutsFree Confirmed Setup With Expert Accuracy - Newser
Cytek Biosciences Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming Entry Zone Forecast for Momentum Trading - Newser
Bank of New York Mellon Corp Sells 38,307 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
What are Cytek Biosciences Inc. company’s key revenue driversRapid market gains - jammulinksnews.com
Will Cytek Biosciences Inc. Stock Benefit from AI and Green Energy TrendsMinimized Risk Trading Plan - metal.it
What are the latest earnings results for Cytek Biosciences Inc.High-impact stock picks - jammulinksnews.com
What catalysts could drive Cytek Biosciences Inc. stock higher in 2025Free Wealth Management Insights - jammulinksnews.com
Intrinsic Value of Cytek Biosciences Inc. Stock: Is It Undervalued or OvervaluedFree VIP Investment Strategies - Newser
How Cytek Biosciences Inc. stock performs during market volatilityFree Stock Market Practical Discussion Forums - Newser
Is Cytek Biosciences Inc. a good long term investmentOutperformance with explosive growth - PrintWeekIndia
What analysts say about Cytek Biosciences Inc. stock outlookConsistently exceptional gains - jammulinksnews.com
What drives Cytek Biosciences Inc. stock pricePowerful market insights - PrintWeekIndia
Why Cytek Biosciences Inc. stock attracts strong analyst attentionAnalyst Grade Signals - Newser
What analysts say about Cytek Biosciences Inc. stockSky-high profits - Autocar Professional
10 Promising SmallCap Stocks Under $1 Billion Market Cap - Insider Monkey
Cytek Biosciences, Inc. (CTKB): A Bull Case Theory - Insider Monkey
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewswire
Cytek Biosciences Inc. Stock Analysis and ForecastExceptional gains - Autocar Professional
Cytek Biosciences to Release Second Quarter 2025 Financial Results on August 6, 2025 - Nasdaq
Cytek Biosciences Schedules Q2 2025 Earnings Call: Key Financial Results Coming August 6 - Stock Titan
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):